LY01005: Clinical Trials

1 trial of LY01005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow LY01005: new trials by email Literature Review of LY01005 trials Research Report on LY01005

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
LY01005, ZOLADEX® 3.6 mg - Breast Cancer
Phase 3CompletedLuye Pharma Group Ltd.1882020-10-152023-05-16

Conditions studied

Breast Neoplasms (1)

Sponsors

Luye Pharma Group Ltd. (1)

Countries

China (1)